8-K Announcements
6Material company update
Jan 16, 2026·SEC
Material company update
Jan 13, 2026·SEC
Material company update
Dec 12, 2025·SEC
Semler Scientific has undergone a fundamental transformation, shifting from a high-margin medical device provider to a firm heavily exposed to digital asset volatility. While the core QuantaFlo platform maintains a robust 91.5% gross margin, the company faces ...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q1 2026Latest Feb 17, 2026 | $3.41+731.5% vs -$0.54 | — vs $3M |
Q4 2025 Nov 12, 2025 | $1.07+2575.0% vs $0.04 | $7M-9.6% vs $8M |
Q3 2025 Aug 4, 2025 | $5.04+5140.0% vs -$0.10 | $8M+2.8% vs $8M |
Q2 2025 May 13, 2025 | -$6.74 vs — | $9M vs — |
Benchmark SMLR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Semler Scientific, Inc. (SMLR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $20.33 | $310.75M | 3.96 | -17.44% | 72.65% | 27.04% | — | |
| $0.39 | $21.59M | -0.63 | — | — | -686.78% | — | |
| $7.14 | $89.2M | -28.56 | 14.52% | -10.92% | -108.8% | — | |
| $0.58 | $5.94M | -1.06 | 47901.74% | -64.79% | -26.76% | — | |
| $10.03 | $1.54B | -10.45 | 24.95% | -13.5% | -818.99% | — | |
| $4.77 | $695.28M | 14.91 | 19.99% | 1.76% | 2.61% | — |
Semler Scientific, Inc. (SMLR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Semler Scientific, Inc. (SMLR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jan 16, 2026·SEC
Jan 13, 2026·SEC
Dec 12, 2025·SEC
Nov 12, 2025·SEC
Get notified when SMLR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Semler Scientific, Inc. (SMLR) stock FAQ — growth, dividends, profitability & financials explained
Semler Scientific, Inc. (SMLR) reported $37.0M in revenue for fiscal year 2024. This represents a 11595% increase from $0.3M in 2011.
Semler Scientific, Inc. (SMLR) saw revenue decline by 17.4% over the past year.
Yes, Semler Scientific, Inc. (SMLR) is profitable, generating $48.3M in net income for fiscal year 2024 (72.7% net margin).
Semler Scientific, Inc. (SMLR) has a return on equity (ROE) of 27.0%. This is excellent, indicating efficient use of shareholder capital.
Semler Scientific, Inc. (SMLR) had negative free cash flow of $388.7M in fiscal year 2024, likely due to heavy capital investments.